Which COVID-19 Patients Die in Intensive Care Unit (ICU) in Turkey

Which COVID-19 Patients Die in Intensive Care Unit (ICU) in Turkey

Objective: The World Health Organization labelled the COVID-19 outbreak a pandemic on March 11, 2020, the first day COVID-19 cases were diagnosed in Turkey. Since then, people's main concerns have been whether their lives or the lives of their relatives would be at risk if they became infected. The objective of this study was to determine the risk factors that increase mortality in COVID-19 patients treated in ICUs and to facilitate the appropriate precautions. Methods: In this study, patients who were diagnosed with COVID-19 [positive on a polymerase chain reaction (PCR) test] and monitored in the Pandemic Hospital at Diyarbakır Dicle University between 15 March 15 and 15 May, 2020, were evaluated for risk factors for mortality. Results: A total of 50 ICU patients were included in the study. Of them, 52% were males, and the mean age was 63.8±17.6 years. A comparison of deceased and surviving patients showed that being female, older than 62, and a smoker and having diabetes mellitus, hypertension, and/or coronary artery disease significantly increased mortality. An investigation of the findings from the patients' lung tomography examinations revealed that relatively prominent pulmonary involvement and localization did not affect mortality. Conclusions: Because patients who are advanced in age, female and smokers and have comorbidities are in the high-risk group, measurements related to treating the COVID-19 disease should be improved. Laboratory parameters are useful for the evaluation of mortality and morbidity, while mechanical ventilation increased mortality.

___

  • 1. Bhatraju PK, Ghassemieh BJ, Nichols M, et al. Covid-19 in Critically Ill Patients in the Seattle Region - Case Series. N Engl J Med. 2020 May 21; 382: 2012-22.
  • 2. Arentz M, Yim E, Klaff L, et al. Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State. JAMA. 2020 Apr 28; 323: 1612- 4.
  • 3. Gold JAW, Wong KK, Szablewski CM, et al. Characteristics and clinical outcomes of adult patients hospitalized with COVID-19- Georgia. MMWR. 2020 March; 69: 545-50.
  • 4. Du Y, Tu L, Zhu P, et al. Clinical features of 85 fatal cases of COVID-19 from Wuhan. A retrospective observational study. Am J Respir Crit Care Med. 2020; 201: 1372-9.
  • 5. Nikpouraghdam M, Farahani AJ, Alishiri G, et al. Epidemiological characteristics of coronavirus disease 2019 (COVID-19) Patients in Iran: A single center study. J Clin Virol. 2020; 127: 104378.
  • 6. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID 19 in Wuhan, China: A retrospective cohort study. Lancet. 2020; 395(10229): 1054-62.
  • 7. Zhang N, Xu X, Zhou L, et al. Clinical characteristics and chest CT imaging features of critically ill COVID 19 patients. Eur Radiol. 2020; 1-10.
  • 8. Yuan M, Yin W, Tao Z, Tan W, Yi Hu. Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China. PLoS One. 2020; 15: e0230548.
  • 9. Frater JL, Zini G, d'Onofrio G, Rogers HJ. COVID-19 and the clinical hematology laboratory. Int J Lab Hematol. 2020; 42 Suppl 1: 11-8.
  • 10. Lu G, Wang J. Dynamic changes in routine blood parameters of a severe COVID-19 case. Clin Chim Acta. 2020; 508: 98-102.
  • 11. Kavsak PA, de Wit K, Worster A. Emerging key laboratory tests for patients with COVID-19. Clin Biochem. 2020; 81: 13-14.
  • 12. Adelman D. Thousands of lives could be saved in the US during the COVID-19 pandemic if states exchanged ventilators. Health Aff (Millwood). 2020; 39: 1247-52.
  • 13. Wang Y, Lu X, Li Y, et al. Clinical course and outcomes of 344 intensive care patients with COVID 19. Am J Respir Crit Care Med. 2020 Jun 1; 201: 1430-4.
  • 14. Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA. 2020; 323: 2052-59.
  • 15. Du RH, Liu LM, Yin W, et al. Hospitalization and critical care of 109 decedents with COVID-19 pneumonia in Wuhan, Ann Am Thorac Soc. 2020 Jul; 17: 839-46.
Dicle Tıp Dergisi-Cover
  • ISSN: 1300-2945
  • Yayın Aralığı: Yılda 4 Sayı
  • Başlangıç: 1963
  • Yayıncı: Cahfer GÜLOĞLU
Sayıdaki Diğer Makaleler

Enjeksiyon Nöropatisi Olgularında Siyatik Sinir Tutulumunun ve Derecesinin Değerlendirilmesi

Vasfiye KABELOĞLU, Aysun SOYSAL, Dilek ATAKLI, Aysu ŞEN, Zeynep BAŞTUĞ GÜL

Investigation of Relation between Abdominal Aortic Calcium Score and Renal Stone via Multislice Computed Tomography

Duran EFE, Fatih AYGÜN

Oral Antidiyabetik Kullanımının, Farklılaşmış 3T3-L1 Hücrelerinde Adipogenez Metabolizmasında Görev Alan VDR, SIRT1, Apelin ve FOXO1 Gen Anlatım Seviyelerine Etkileri

Meliha KOLDEMİR GÜNDÜZ, Mehtap ÇEVİK, Penbe ÇAĞATAY, Çavlan ÇİFTÇİ, Belgin SÜSLEYİCİ

Multipl Skleroz Hastalarında Trombosit Endekslerinin ve Klinik Bulgular ile İlişkilerin Değerlendirilmesi

Alevtina ERSOY, Ceyda TANOĞLU

Impact of the COVID-19 Pandemic on Anxiety and Depression Levels in Pregnant Women

Gokce TURAN, Mehmet Zeki TANER, Ayla ESER, Ayse Duygu TUFAN, Cem TERECE, Hasan Huseyin UCKAN, Tuncay NAS

Pankreas Kanseri Tanılı Hastalarımızda Prognostik Faktörlerin İncelenmesi

Ramazan YOLAÇAN, Ercan YİĞİT, Ümit KARABULUT, Ali ÜZEL, Feyzullah UÇMAK, Muhsin KAYA

hCG Günü Serum Estradiol ve Progesteron Değerleri, Antagonist Protokollü IVF-ICSI Sikluslarında Tedavi Başarısını Etkiler mi?

Uğur DEĞER, Yunus ÇAVUŞ, Gülcan OKUTUCU, Nurullah PEKER

Alt Solunum Yolu Enfeksiyonu Olan Çocuklarda Respiratory Syncytial Virus (RSV) Enfeksiyon İnsidansının Araştırılması

Hatice Hale GÜMÜŞ, Fügen YARKIN

Multipl Sklerozda Ölüm Nedenleri

Sedat ŞEN, Murat TERZİ

Deneysel İskemi / Reperfüzyon Modeli Uygulanmış Dişi Sıçanlarda Tuba Uterina Dokusuna Pycnogenol ’un Etkisinin Değerlendirilmesi

Mukadder SUNAR, Gülce Naz YAZICI